Intra-Cellular Therapies Inc.

Q2 2023 13F Holders

Symbol
ITCI
CUSIP
46116X101
Type
Equity
Class
COM
Num filers
293
Total reported value, excl. options
$5.34B
Manager Report Date Value ($000) Shares Option Type